Adult Vaccine Coadministration Is Safe, Effective, and Acceptable: Results of a Survey of the Literature
Litjen Tan,
No information about this author
Dana Trevas,
No information about this author
Ann R. Falsey
No information about this author
et al.
Influenza and Other Respiratory Viruses,
Journal Year:
2025,
Volume and Issue:
19(3)
Published: March 1, 2025
Coadministration
of
vaccines
in
children
is
a
long-standing
practice
that
has
proven
to
be
safe
and
effective
improving
the
efficiency
vaccine
administration,
thereby
increasing
immunization
coverage
rates.
As
number
routinely
recommended
for
adults
increases,
with
limited
opportunities
have
preventive
health
touchpoints
providers,
adult
coadministration
should
considered
as
routine
improve
vaccination
rates
public
health.
A
review
existing
literature
was
conducted
examine
potential
reactogenicity
impact
on
effectiveness
when
co-administering
adults.
Medline
searched
research
articles
search
term
"influenza
vaccine"
or
"vaccination,"
combined
terms
"simultaneous,"
"concomitant,"
"concurrent,"
"combination."
Another
"vaccination"
following
individual
terms:
"RSV,"
"COVID,"
"Tdap."
The
references
extracted
were
also
examined
other
relevant
articles.
Adult
all
combinations
we
assessed.
Most
adverse
events
(AEs)
generally
mild
moderate
short
duration.
Some
studies
showed
slightly
more
but
few
no
serious
AEs
safety
signals.
Nearly
every
study
confirmed
had
significant
effect
immune
response
either
vaccine.
benefits
outweigh
risks.
It
increases
convenience
vaccinees,
reduces
missed
vaccinate,
contributes
efficient
use
healthcare
resources.
Language: Английский
Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 381 - 381
Published: April 2, 2025
Background/Objectives:
Co-administration
of
BNT162b2
with
licensed
seasonal
influenza
vaccines
(SIVs)
is
recommended
by
health
authorities.
We
provide
a
comprehensive
summary
the
data
supporting
this
practice
in
adults.
Methods:
This
systematic
review
consolidates
available
evidence
on
prevalence,
safety,
immunogenicity,
efficacy,
and
effectiveness
co-administering
SIVs.
Searches
were
conducted
for
English
studies
adults
≥
18
years
age
between
January
2021
August
2024,
no
geographic
restriction.
Study
quality
was
assessed
using
Cochrane
RoB
2.0
Newcastle–Ottawa
Scale.
Results:
Twenty
(15
observational
5
clinical
trials)
included,
mainly
seven
countries
Europe
North
America.
Eight
reported
twelve
safety/reactogenicity,
six
three
evaluated
efficacy/effectiveness.
Reported
co-administration
SIVs
increased
over
time.
Of
persons
receiving
BNT162b2,
proportion
that
co-administered
from
2.7%
to
34.1%
2023.
Although
variability
outcomes
observed,
consistent
pattern
indicating
negative
impact
immunogenicity
same-day
identified.
Effectiveness
not
observed
change
when
BNT162B2
The
incidence
systemic
local
adverse
events
comparable
individuals
separately
those
them
co-administered.
Conclusions:
findings
indicate
both
safe
effective.
highlights
value
co-administration,
which
could
enhance
vaccine
uptake
streamlining
immunization
protocols
reducing
visits.
Language: Английский
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza
Eliel Nham,
No information about this author
Ji Yun Noh,
No information about this author
Ok Hyun Park
No information about this author
et al.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(5), P. 514 - 514
Published: May 9, 2024
Coronavirus
disease
2019
(COVID-19)
is
a
highly
contagious
zoonotic
respiratory
with
many
similarities
to
influenza.
Effective
vaccines
are
available
for
both;
however,
rapid
viral
evolution
and
waning
immunity
make
them
virtually
impossible
eradicate
vaccines.
Thus,
the
practical
goal
of
vaccination
reduce
incidence
serious
illnesses
death.
Three
years
after
introduction
COVID-19
vaccines,
optimal
strategy
in
endemic
period
remains
elusive,
health
authorities
worldwide
have
begun
adopt
various
approaches.
Herein,
we
propose
based
on
data
until
early
2024
discuss
aspects
that
require
further
clarification
better
decision
making.
Drawing
from
comparisons
between
influenza
strategies,
our
proposed
prioritizes
high-risk
groups,
emphasizes
seasonal
administration
aligned
campaigns,
advocates
co-administration
increase
coverage.
Language: Английский
Simultaneous vaccination against seasonal influenza and COVID-19 among the target population in Italy
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: Aug. 6, 2024
Annual
influenza
and
COVID-19
vaccinations
are
effective
tools
for
reducing
the
disease
burden.
The
goals
of
present
cross-sectional
survey
were
to
investigate
attitudes
behaviors
toward
simultaneous
vaccination
against
seasonal
factors
associated.
Language: Английский